Home » Dr. Susan Blaney awarded the Collaborative Activity Seed Grant
August 25, 2008 – Texas Children’s Hospital
by Corbin B.P. Dodge
Dr. Susan Blaney, Deputy Director of the Texas Children’s Cancer Center and Hematology Service, and Director of the Neuro-Oncology and Clinical Pharmacology Program’s has been awarded the Collaborative Activity Seed Grant. This grant is central to the development of the Pediatric Oncology Nanotechnology Initiative, an inter-institutional collaboration with Rice University, will lay the groundwork for the development of innovative approaches to the diagnosis, treatment, and prevention of childhood cancer.
“There are no other centers that we know of that have specifically initiated an effort in this area. Our goals are to develop and implement new therapies for children based on the exciting promises in the field of nanotechnology,” said Dr. Blaney. “We want to develop therapies that are specifically targeted to the tumor and that aren’t associated with the toxicities of traditional chemotherapy.”
In collaboration with Dr. Jennifer West, Chair of Bioengineering at Rice University, Dr. Blaney hopes to build on the pioneering work of Dr. West in the area of nanotechnology.
“Dr. West’s research has resulted in adult clinical trials utilizing nanotechnology approaches for the treatment of cancer, we’d like to build from that experience for the treatment of childhood cancers”, said Dr. Blaney.
The Gulf Coast Consortia along with the W.M. Keck Foundation are providing support for the grant. The Gulf Coast Consortia’s cutting-edge training environment allows enables the next generation of scientists to challenge biological issues and to apply the knowledge learned to the discovery of treatments and prevention of disease. The GCC is compromised of six institutions: Baylor College of Medicine, Rice University, University of Houston, University of Texas Health Science Center at Houston, University of Texas Medical Branch at Galveston, and University of Texas M.D. Anderson Cancer Center. Their fields range from chemical genomics to nanobiology and the GCC has been publicly acknowledged for their benefits, capabilities, and effectiveness.
The W.M. Keck Foundation has become one of the world’s largest philanthropic organizations. Their goals are much like the GCC’s: lay the groundwork for breakthrough discoveries that will save lives.
“We’re thrilled the GCC has provided us with seed funding for this exciting new initiatve,” said Dr. Blaney, “This will serve as a catalyst to bring investigators from Texas Children’s Cancer Center and scientists at Rice to develop further nanotechnology collaborations.”